FDA Inspection
Cardinal Health 414, Inc.Cardinal Health 414, Inc. – FDA Inspection, Feb 25, 2020
Record Details
This FDA Inspection record concerns Cardinal Health 414, Inc., with an inspection on February 25, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Cardinal Health 414, Inc.
- Inspection Date
- February 25, 2020
- Product Type
- Drugs
View Company Profile
ID · d7de24bf-433e-4bf5-be5d-8bb6f42ad82e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1118917
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 212.20(d)Determination need for investigation
- 21 CFR 212.20(e)Written QA procedures established, followed
- 21 CFR 212.50Adequate controls (general)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cardinal Health 414, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 13, 2025 | VAI | Seattle District Office | Drug Quality Assurance |
| January 25, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 3, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 14, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 17, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cardinal Health 414, Inc.
- FDA Inspection 1273848 - 2025-06-13
- FDA Inspection 1038753 - 2018-01-25
- FDA Inspection 961781 - 2015-11-03
- FDA Inspection 810926 - 2012-12-14
- FDA Inspection 582328 - 2009-04-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.